Skip to content

US · HYPD · MEDICAL - DEVICES

Hyperion DeFi, Inc. (HYPD) intrinsic value and stock valuation

$2.08as of 2026-11-21 · Mkt cap 41.38M

Data updated · price as of 2026-11-21

IC valuationIntrinsic value, upside vs price and the fair-value band are available to Pro members.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

Hyperion DeFi, Inc. DCF and intrinsic value

InvestorsCraft values HYPD with the Chepakovich two-stage DCF model. How the model works · Run your own DCF prefilled from HYPD’s statements →

Hyperion DeFi, Inc. Graham Number

The Graham Number is not defined for negative earnings or book value. Guide · Calculator →

Healthcare · Medical - Devices Dallas, TX 75219 hyperiondefi.com

How the business is doing

Fiscal 2020–2025, USD

Revenue
$810K-16.5% 5y CAGRd
20202025
Net income
-$-45.31M
20202025
Free cash flow
-$-14.77M
20202025
Total equity
$41.1M+21.8% 5y CAGRd
20202025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2020–2025, USD
20252024202320222021
Revenue$810K$60K$0.00$0.00$14M
Operating income-$-18.98M-$-48.74M-$-25.41M-$-26.91M-$-13.02M
Net income-$-45.31M-$-49.82M-$-27.26M-$-28.01M-$-12.78M
EPSd-$-9.06M-$-60.02M-$-53.45M-$-66.69M-$-38.73M
Operating cash flow-$-14.77M-$-30.12M-$-23.84M-$-25.11M-$-20.87M
Capital expenditure$0.00-$-160K-$-3.97M-$-870K-$-1.62M
Free cash flow-$-14.77M-$-30.28M-$-27.81M-$-25.98M-$-22.49M
Total assets$51.8M$3.67M$28.8M$31M$31.7M
Total debt$8.51M$11.2M$16.1M$10.1M$7.15M
Net debt$2.07M$9.12M$1.23M-$-12.74M-$-12.31M
Total equity$41.1M-$-13.1M$9M$17.2M$20.5M
Cash and short-term investments$6.44M$2.12M$14.9M$22.9M$19.5M
Income statement
20252024202320222021
Revenue$810K$60K$0.00$0.00$14M
Cost of revenue$300K$3.93M$20K$0.00$1.6M
Gross profit$510K-$-3.87M-$-10K$0.00$12.4M
Research and development expenses$1.91M$14.5M$13M$13.4M$14.9M
Selling, general and administrative expenses$17.2M$14.3M$12.4M$14.5M$10.6M
Other expenses$410K$16.1M$0.00-$-990K$0.00
Operating expenses$19.5M$44.9M$25.4M$26.9M$25.4M
Cost and expenses$19.8M$48.8M$25.4M$26.9M$27M
Interest income$240K$250K$690K$80K$0.00
Interest expense$1.56M$2.48M$2.37M$1.38M$390K
Depreciation and amortization$0.00$1.13M$780K$310K$220K
Ebitda-$-43.76M-$-46.21M-$-24.11M-$-26.32M-$-12.17M
Operating income-$-18.98M-$-48.74M-$-25.41M-$-26.91M-$-13.02M
Total other income/expenses, net-$-26.33M-$-1.08M-$-1.85M-$-1.1M$240K
Income before tax-$-45.31M-$-49.82M-$-27.26M-$-28.01M-$-12.78M
Income tax expense$0.00$0.00$0.00$0.00$0.00
Net income-$-45.31M-$-49.82M-$-27.26M-$-28.01M-$-12.78M
Weighted average shares outstanding$5M$830K$510K$420K$330K
Weighted average diluted shares outstanding$5M$830K$510K$420K$330K
Balance sheet
20252024202320222021
Cash and short-term investments$6.44M$2.12M$14.9M$22.9M$19.5M
Net receivables$260K$20K$120K$1.18M$1.81M
Inventory$0.00$0.00$110K$0.00$0.00
Total current assets$7.25M$2.77M$20.7M$27.6M$22M
Property, plant and equipment, net$16.8M$720K$5.04M$2.59M$1.27M
Goodwill and intangible assets$20.6M$0.00$2.12M$0.00$0.00
Long-term investments$6.94M$0.00$0.00$0.00$0.00
Total non-current assets$44.5M$900K$8.07M$3.39M$9.66M
Total assets$51.8M$3.67M$28.8M$31M$31.7M
Accounts payable$320K$2.2M$1.75M$1.43M$1.61M
Short-term debt$510K$10.5M$5.83M$830K$7.15M
Deferred revenue$0.00$0.00$0.00$0.00$0.00
Total current liabilities$2.7M$16.1M$9.53M$4.51M$11.2M
Long-term debt$8M$720K$10.3M$9.29M$0.00
Deferred revenue, non-current$0.00$0.00$0.00$0.00$0.00
Total non-current liabilities$8M$720K$10.3M$9.29M$20K
Capital lease obligations$720K$1.29M$1.79M$1.39M$0.00
Total liabilities$10.7M$16.8M$19.8M$13.8M$11.2M
Common stock$0.00$0.00$0.00$0.00$0.00
Retained earnings-$-240.62M-$-195.31M-$-145.49M-$-118.23M-$-90.22M
Accumulated other comprehensive income (loss)$0.00$0.00$0.00-$0.00$0.00
Total equity$41.1M-$-13.1M$9M$17.2M$20.5M
Total investments$6.94M$0.00$0.00$0.00$0.00
Total debt$8.51M$11.2M$16.1M$10.1M$7.15M
Net debt$2.07M$9.12M$1.23M-$-12.74M-$-12.31M
Cash flow statement
20252024202320222021
Net income-$-45.31M-$-49.82M-$-27.26M-$-28.01M-$-12.78M
Depreciation and amortization$0.00$1.13M$780K$310K$220K
Stock-based compensation$6.37M$1.7M$2.5M$3.77M$2.89M
Change in working capital-$-2.91M-$-340K-$-1.48M-$-2.26M-$-10.7M
Accounts receivable$0.00$100K$1.06M$620K$1.4M
Inventory$0.00$0.00-$-120K$0.00$0.00
Accounts payable-$-1.64M$450K$320K-$-190K$130K
Net cash provided by operating activities-$-14.77M-$-30.12M-$-23.84M-$-25.11M-$-20.87M
Investments in property, plant and equipment-$-71.95M-$-160K-$-2.85M-$-870K-$-1.62M
Acquisitions, net$0.00$0.00$0.00$0.00$0.00
Net cash used for investing activities-$-71.95M-$-160K-$-3.97M-$-870K-$-1.62M
Common stock issued$93.5M$25.6M$16.7M$20.4M$12.8M
Common stock repurchased$0.00$0.00$0.00$0.00$0.00
Dividends paid-$-890K$0.00$0.00$0.00$0.00
Net cash used for financing activities$91.1M$17.6M$19.8M$21.5M$21.5M
Net change in cash$4.32M-$-12.73M-$-8.01M-$-4.47M-$-1.03M
Cash at end of period$6.44M$2.12M$14.9M$22.9M$27.3M
Operating cash flow-$-14.77M-$-30.12M-$-23.84M-$-25.11M-$-20.87M
Capital expenditure$0.00-$-160K-$-3.97M-$-870K-$-1.62M
Free cash flow-$-14.77M-$-30.28M-$-27.81M-$-25.98M-$-22.49M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About Hyperion DeFi, Inc.

        Operating from the United States, Hyperion DeFi, Inc. is a company undergoing a significant shift from its foundational work in ophthalmic drug-delivery, known as Optejet. Its current trajectory involves establishing itself as the inaugural U.S. firm on Nasdaq to hold a cryptocurrency treasury, predominantly denominated in HYPE tokens originating from the Hyperliquid blockchain. Furthermore, Hyperion DeFi oversees the "Kinetiq × Hyperion" validator, persists with its decentralized finance (DeFi) staking strategies, and continues to advance its Optejet UFD™ technology for ocular health.

        CEO
        Hyunsu Jung
        Employees
        9
        Beta
        2.50

        Explore

        Frequently asked questions

        What is the intrinsic value of Hyperion DeFi, Inc. (HYPD)?

        InvestorsCraft does not currently publish an intrinsic value for HYPD. How the IC value is calculated.

        Is HYPD undervalued?

        InvestorsCraft does not publish an undervaluation signal for HYPD at this time.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.